Details for New Drug Application (NDA): 062499
✉ Email this page to a colleague
NDA 062499 describes LANABIOTIC, which is a drug marketed by Combe and is included in two NDAs. Additional details are available on the LANABIOTIC profile page.
The generic ingredient in LANABIOTIC is bacitracin zinc; lidocaine; neomycin sulfate; polymyxin b sulfate. There are twenty-seven drug master file entries for this compound. Additional details are available on the bacitracin zinc; lidocaine; neomycin sulfate; polymyxin b sulfate profile page.
The generic ingredient in LANABIOTIC is bacitracin zinc; lidocaine; neomycin sulfate; polymyxin b sulfate. There are twenty-seven drug master file entries for this compound. Additional details are available on the bacitracin zinc; lidocaine; neomycin sulfate; polymyxin b sulfate profile page.
Summary for 062499
| Tradename: | LANABIOTIC |
| Applicant: | Combe |
| Ingredient: | bacitracin zinc; lidocaine; neomycin sulfate; polymyxin b sulfate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | OINTMENT;TOPICAL | Strength | 400 UNITS/GM;40MG/GM;EQ 5MG BASE/GM;5,000 UNITS/GM | ||||
| Approval Date: | Jun 3, 1985 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
